Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Short term Debt data on file, last reported at $9.2 million in Q4 2025.

• Short term Debt for Q4 2025 came in at $9.2 million, down 11.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.2 million (down 11.43% YoY), and the FY2025 annual result was $100000.0, down 99.02% from the prior year.
• Short term Debt advanced to $9.2 million in Q4 2025 per ZYBT's latest filing, from $28000.0 in the prior quarter.
• Over five years, Short term Debt peaked at $11.1 million in Q4 2023 and troughed at $28000.0 in Q2 2025.
• A 3-year average of $7.7 million and a median of $9.8 million in 2024 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2024 and 2025: Short term Debt decreased 6.56% in 2024, then fell 11.43% in 2025.
• A 3-year view of Short term Debt shows it stood at $11.1 million in 2023, then fell by 6.56% to $10.4 million in 2024, then declined by 11.43% to $9.2 million in 2025.
• Business Quant data shows ZYBT's Short term Debt at $9.2 million in Q4 2025, $28000.0 in Q2 2025, and $10.4 million in Q4 2024.